CD44 is prognostic for overall survival in the NCI randomized trial on breast conservation with 25 year follow-up

T. Dan, S. M. Hewitt, N. Ohri, D. Ly, B. P. Soule, S. L. Smith, K. Matsuda, C. Council, U. Shankavaram, M. E. Lippman, J. B. Mitchell, K. Camphausen, N. L. Simone

Research output: Contribution to journal › Article › peer-review